A phase I/II study of siltuximab (CNTO) an anti-interleukin-6 monoclonal antibody in metastatic renal cell cancer

JF Rossi, S Negrier, ND James, I Kocak, R Hawkins, H Davis, U Prabhakar, X Qin, P Mulders, B Berns

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{975638136c564535991655b84042158f,

title = "A phase I/II study of siltuximab (CNTO) an anti-interleukin-6 monoclonal antibody in metastatic renal cell cancer",

author = "JF Rossi and S Negrier and ND James and I Kocak and R Hawkins and H Davis and U Prabhakar and X Qin and P Mulders and B Berns",

year = "2010",

language = "English",

volume = "38",

pages = "1154--1162",

journal = "Br J Cancer",

issn = "1532-1827",

publisher = "Springer Nature",

number = "6",

}

TY - JOUR

T1 - A phase I/II study of siltuximab (CNTO) an anti-interleukin-6 monoclonal antibody in metastatic renal cell cancer

AU - Rossi, JF

AU - Negrier, S

AU - James, ND

AU - Kocak, I

AU - Hawkins, R

AU - Davis, H

AU - Prabhakar, U

AU - Qin, X

AU - Mulders, P

AU - Berns, B

PY - 2010

Y1 - 2010

M3 - Article

SN - 1532-1827

VL - 38

SP - 1154

EP - 1162

JO - Br J Cancer

JF - Br J Cancer

IS - 6

ER -